Cannabis Edibles Can Impair Driving Even When Blood THC Looks Low
A randomized clinical trial found measurable driving impairment at 10 mg and 20 mg of edible THC while blood levels stayed near or below common legal limits.
A randomized clinical trial published in JAMA Network Open on August 31, 2026 found that 10 mg and 20 mg THC edibles impaired simulated driving in regular cannabis consumers, while blood THC in those same participants stayed near or below the limits many states use to define impairment. You can be measurably worse at driving and still look clean on a blood test. The practical upshot is simple: decide how you are getting home before you eat the edible, because neither your own sense of how high you feel nor a blood number is a reliable green light.
Here is what the trial found and where its limits sit.
- The doses that mattered: 10 mg and 20 mg THC edibles caused measurable lane-control problems in a driving simulator. The 2 mg dose did not.
- The blood gap: average peak blood THC was 1.6 ng/mL after 10 mg and 3.4 ng/mL after 20 mg. Only 8 of 294 acute blood samples exceeded 5 ng/mL.
- Self-assessment is partial: participants' ratings of their own driving ability tracked their actual impairment only partway.
- No safe waiting period: effects varied by dose, tolerance, and metabolism. The study cannot tell you when you are clear.
This article is general information, not medical or legal advice. Cannabis can impair driving. Never drive impaired, and confirm the impaired-driving rules where you live with a licensed attorney or your state authority.
JAMA Network Open: Effects of THC edibles on simulated driving performance — The randomized, double-blind, placebo-controlled crossover trial this article covers.
What the researchers actually tested
The trial used a randomized, double-blind, placebo-controlled crossover design. Every participant completed every condition. No one knew which dose they received on a given day, and one condition contained no THC at all. That design filters out expectation effects and individual differences more reliably than most other research setups, which matters when you are trying to isolate what a specific dose does to driving.
Researchers enrolled 40 healthy adults ages 19 to 45. All used cannabis at least weekly and edibles at least monthly. Experienced consumers, in other words, and the group most likely to assume a standard dose is fine and that they would notice if it was not.
Each participant completed four sessions: placebo, 2 mg, 10 mg, and 20 mg of THC in edible form. Driving simulator testing happened at two, five, and 24 hours after consumption.
The primary measure was lane-position variability, which tracks how much a vehicle weaves within its lane. Secondary measures included reaction time, speed consistency, self-rated driving ability, and blood cannabinoid levels. The Centre for Addiction and Mental Health reported the findings alongside publication.
How driving performance changed at each dose
Lane control at 10 mg and 20 mg
Lane-position variability increased by 2.0 cm after the 10 mg dose compared with placebo. It increased by 3.3 cm after 20 mg. The 2 mg dose produced no significant change on this primary measure.
Prior research summarized by Psychiatric Times notes that a 2.4 cm increase in lane variability corresponds to impairment comparable to a 0.05% blood alcohol concentration. The 20 mg dose in this trial exceeded that benchmark.
Reaction time and speed control
Reaction time slowed significantly at 20 mg. Speed variability also increased at 20 mg. Performance measures did not shift identically at every dose, because impairment shows up unevenly across different driving skills.
What participants thought about their own driving
As doses went up, participants reported less willingness to drive and less confidence in their own ability. Their read on themselves moved in the right direction. It just did not move far enough to match what the simulator was recording.
Related research reviewed in Current Addiction Reports found that participants in other studies were willing and ready to drive shortly after using cannabis while their skills remained objectively impaired. Subjective confidence is not a reliable measure of actual ability.
Why blood THC stayed low while driving got worse
Peak blood THC averaged just 1.6 ng/mL after the 10 mg dose and 3.4 ng/mL after the 20 mg dose. Of 294 valid acute blood samples collected during the study, only eight exceeded 5 ng/mL.
Driving was still impaired at both doses. The blood simply did not show it.
Several states set legal per se limits at or near those numbers. Ohio and Nevada use 2 ng/mL. Montana and Washington use 5 ng/mL, according to the Marijuana Policy Project. Under a 5 ng/mL standard, most impaired participants in this trial would have tested below the legal threshold.
Oral THC passes through the digestive system and liver before reaching the bloodstream. That process, called first-pass metabolism, produces lower peak blood concentrations and a later peak than smoking or vaping. The liver also converts THC into 11-hydroxy-THC, a potent metabolite that crosses into the brain efficiently. The effect on driving arrives even when the blood THC number stays modest.
Why edibles create a distinct enforcement problem
A blood sample is a snapshot. Driving impairment plays out across time. Those two things line up poorly when the substance involved peaks late and stays active for hours.
Edibles absorb slowly, peak late, and stay active for hours. The same blood concentration can correspond to very different levels of functional impairment depending on when the sample is drawn and how the cannabis was consumed. Coverage of the study by Fox News framed it as a hidden risk that standard tests miss.
Two separate questions are relevant here, and the study answers only one of them.
- Functional question: is this person impaired right now?
- Legal question: does this measurement meet the standard to prove an offense?
This trial answers the first question. It shows that a common answer to the second one misses cases. Functional assessment and consumer education probably deserve more attention than they currently get.
What the study cannot tell you
Acute testing happened at two and five hours, with a follow-up at 24 hours. Testing was not continuous, so the study cannot pinpoint when impairment ended for any individual.
At the 24-hour mark, most dose-related effects had disappeared. A small residual difference in maximum speed remained after the 10 mg and 20 mg doses.
Limitations worth knowing
- Sample size and site: only 40 participants at a single Toronto research site.
- Population: every participant was a regular cannabis consumer ages 19 to 45, so the findings say nothing certain about occasional consumers, older adults, or first-time users.
- Setting: testing used a driving simulator, not public roads.
- Product: controlled study products may differ from commercial edibles in formulation and absorption.
- Outcome measured: the trial measured driving performance, not collisions. Simulator impairment does not directly prove real-world crash risk.
Public Safety Canada funded the research. Indiva supplied the placebo edibles and reportedly had no role in the analysis or the decision to publish.
What this means for you as a consumer
- Feeling less intoxicated is not the same as being ready to drive. Self-assessments in this trial tracked actual impairment only partway.
- A low blood THC result does not mean someone is unimpaired. This study found objective impairment well below common legal cutoffs.
- Plan transportation before you consume. Deciding after the edible kicks in means deciding with a brain that is already affected.
- Avoid combining cannabis with alcohol or other impairing substances. The risk compounds.
What this means for policymakers
Route of administration matters when reading a THC number. A concentration that means one thing after smoking can mean something quite different after an edible.
Concentration-based rules capture part of the impairment picture, but they miss another part. More research is needed on occasional consumers, real-world driving behavior, and practical roadside assessment tools before anyone can build a system that catches impairment reliably and treats people fairly.
Frequently asked questions
Can cannabis edibles impair driving five hours after consumption?
The trial measured performance at the five-hour mark and found dose-related impairment during the acute testing period. It does not establish a universal duration of impairment for all people and all doses.
Does blood THC below 5 ng/mL mean someone is safe to drive?
No. In this trial, participants showed objective impairment while only eight of 294 acute blood samples exceeded 5 ng/mL. Blood testing still provides useful evidence in many contexts, but it cannot rule out impairment on its own.
Is 2 mg of THC safe before driving?
The 2 mg dose did not significantly change the primary lane-control measure in this group of regular consumers. The study does not establish 2 mg as safe for driving for any individual.
How did researchers measure driving ability?
Participants completed sessions in a driving simulator that recorded lane-position variability, reaction time, and speed consistency at two, five, and 24 hours after consumption.
Did the study find impairment the following day?
Most measured effects were gone at 24 hours. One limited finding remained: a small difference in maximum speed after the 10 mg and 20 mg doses.
Do the findings apply to occasional cannabis consumers?
That remains unknown. Every participant used cannabis at least weekly, and occasional consumers often respond more strongly to the same dose. Research in that population is still needed.
Why do edibles affect blood THC differently than smoking?
Oral THC is processed through the digestive system and liver before entering the bloodstream. That first-pass metabolism converts THC into 11-hydroxy-THC, a potent metabolite that reaches the brain effectively, even when parent THC concentrations in blood remain low.
Can you use tolerance to predict when you are safe to drive after an edible?
This study does not support that. All participants were regular consumers with built-up tolerance, and measurable impairment still showed up at 10 mg and 20 mg. Tolerance did not screen it out.
Key takeaways
- The finding: a rigorous clinical trial found that 10 mg and 20 mg THC edibles impaired simulated driving in regular cannabis consumers.
- The blood numbers: peak blood THC averaged 1.6 ng/mL and 3.4 ng/mL respectively, and only 8 of 294 blood samples exceeded 5 ng/mL.
- The mechanism: oral THC is processed by the liver before reaching the bloodstream, producing lower blood concentrations while the brain effects remain real and measurable.
- The legal gap: many state per se limits would not have flagged the impaired participants in this trial.
- The two unreliable signals: feeling less intoxicated and testing below a legal limit are both poor ways to judge readiness to drive after an edible.
- The policy point: regulators need better tools than blood THC concentration alone as edibles become a larger share of consumption.
The Cannible Newsroom's take
What we would tell a friend is short. If you eat an edible, you are not driving that day. Not because a study said 10 mg is dangerous for everyone, it did not, but because the study removed the two shortcuts most people rely on. You cannot feel your way to a safe answer, and a number on a blood test cannot give you one either.
What concerns us is the asymmetry running in both directions. A regular consumer at 20 mg can be weaving more than someone at a 0.05% blood alcohol concentration and still sit under a 5 ng/mL threshold. That is a public safety gap. At the same time, per se limits can catch people who are no longer impaired at all, which is a fairness gap. Both problems come from the same source: using one concentration to stand in for a functional question it was never built to answer.
The nuance worth holding onto is that this trial studied 40 weekly consumers on a simulator in one city. It is strong evidence about a narrow question and weak evidence about crash risk on real roads. The 2 mg result is not permission, it is an absence of a detectable group-level effect in experienced users. Treat it that way.
We will update this article as the law, the data, or the science changes.
Sources and further reading
- JAMA Network Open: the randomized crossover trial of THC edibles and simulated driving
- CAMH: Cannabis edibles can impair driving even when blood THC levels are below legal thresholds
- Fox News: Marijuana users may face hidden driving danger standard tests miss
- Psychiatric Times: How do cannabis edibles affect driving? New research insights
- Current Addiction Reports: review of cannabis use and driving readiness
- Marijuana Policy Project: DUID and medical marijuana per se limits by state
For the impaired-driving rules that apply to you, check your state authority or speak with a licensed attorney. For questions about how cannabis interacts with your medications or health conditions, talk to a physician or pharmacist.
Buying edibles? Plan the dose and the ride together
Dose control starts with knowing what you are buying and who you are buying it from. Browse verified retailers in the Cannible dispensary directory, check the rules and stores in your state, for example New Jersey, and read how to choose a dispensary before your first edible purchase so you can ask the right questions about milligrams per piece and onset time.